Sheel Biotech Complete Financial Statements
In FYNone, Sheel Biotech (SHEEL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 10.9% and ROE of 9.4%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse SHEEL promoter holding to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SHEEL Revenue, Net Profit & EBITDA — Year-on-Year Growth
SHEEL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Also explore SHEEL price trends to track price trends across different timeframes.
SHEEL Income Statement — Revenue, EBITDA & Net Profit
Sheel Biotech revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 10.9%. For live price, earnings ratios and company overview, see SHEEL stock price BSE.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 110 | 102 | 93 | 80 | 71 | 63 |
| Expenses | 0 | 94 | 87 | 78 | 71 | 64 | 57 |
| EBITDA | 0 | 16 | 16 | 15 | 9 | 7 | 7 |
| Operating Profit Margin % | 0.00% | 15.00% | 15.00% | 16.00% | 11.00% | 9.00% | 10.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 2 | 2 | 2 | 2 | 1 | 1 |
| Profit Before Tax | 0 | 14 | 13 | 12 | 6 | 5 | 5 |
| Tax | 0 | 2 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 12 | 11 | 11 | 5 | 5 | 5 |
| Earnings Per Share (₹) | 0.00 | 6.69 | 7.21 | 7.22 | 3.50 | 3.11 | 11.58 |
SHEEL Balance Sheet — Assets, Liabilities & Shareholders' Equity
SHEEL total assets ₹146 Cr, total equity ₹127 Cr, total liabilities ₹ Cr (2026) — ROE 9.4%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 146 | 113 | 106 | 94 | 93 | 82 |
| Current Assets | 128 | 101 | 95 | 83 | 83 | 74 |
| Fixed Assets | 13 | 8 | 7 | 8 | 8 | 8 |
| Capital Work in Progress | 4 | 0 | 0 | 0 | 0 | 0 |
| Investments | 30 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 106 | 99 | 86 | 85 | 75 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 2 | 5 | 11 | 10 | 14 | 12 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 127 | 84 | 73 | 64 | 60 | 57 |
| Share Capital | 20 | 15 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 107 | 69 | 69 | 59 | 56 | 53 |
SHEEL Cash Flow Statement — Operating, Investing & Financing
Sheel Biotech operating cash flow ₹9 Cr, investing ₹-2 Cr, financing ₹-7 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 9 | -1 | 9 | 2 |
| Investing Activities | -2 | 0 | -2 | -2 |
| Financing Activities | -7 | 2 | -7 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 |